We say it all the time, the biotech sector is ever changing as FDA guidelines and patient needs evolve. As the landscape continues to shift among large biotechs and small startups, seeing that 38 of the 59 new therapies approved in 2018 came from small or emerging companies is certainly an impactful statistic!
The biotech industry is becoming the most active group for later-stage pipeline work, and while Big Pharma sees its R&D share drop, emerging life science companies are better prepared to go it alone.
Source: Biotechs getting bigger in late-stage R&D, leaving Big Pharmas behind: report | FierceBiotech
Gemini Staffing Consultants is 100% committed to providing recruiting services to the Life Sciences community that leave both clients and candidates wholly satisfied with our process, approach, professionalism and, most importantly, our level of integrity. The results will typically follow if we adhere to those four core concepts, and our history has shown extraordinary results. For additional information about our company, we invite you to fill out the form below.
